Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072150
Status:
COMPLETED
Last Update Posted:
2013-06-05
First Post:
2003-11-04
Brief Title:
Phase II Trial Of PS-341 Bortezomib In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma
Sponsor:
Organization:
National Cancer Institute NCI